From NDTV
Center-Right Owned by Adani Group (AMG Media)Emcure Pharmaceuticals Share Price Hits 10% Upper Circuit To Touch 52-Week High; Should You Buy?
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
right · 1 outlet
Emcure Pharmaceuticals reported its earnings for the September quarter on November 3, with double-digit revenue growth and operating profit.
— NDTV
RSS excerpt
Emcure Pharmaceuticals reported its earnings for the September quarter on November 3, with double-digit revenue growth and operating profit.
